Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-09 Levy Howard Chief Medical Officer Purchase +639 $3.62 $2K 639
2021-02-09 Levy Howard Chief Medical Officer Purchase +1,670 $4.81 $8K 23,390
2021-02-08 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-08 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2020-08-10 Levy Howard Chief Medical Officer Purchase +1,768 $4.81 $9K 4,268
2020-03-16 Levy Howard Chief Medical Officer Purchase +2,500 $4.05 $10K 2,500
2020-02-10 Levy Howard Chief Medical Officer Grant or award +1,358 $6.23 $8K 1,358
2020-01-23 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000

Page 1 of 1 · 8 trades